Product Details

Verbupi is a sterile, preservative-free injectable formulation that meets British Pharmacopoeia (BP) standards. Specifically, it delivers Bupivacaine Hydrochloride at 0.5% w/v for infiltration and nerve block anaesthesia. Consequently, it provides prolonged local anaesthetic action for a wide range of surgical and procedural settings.

The injection contains:

• Bupivacaine Hydrochloride IP (equivalent to Bupivacaine 5mg per ml) – A long-acting amide-type local anaesthetic that blocks voltage-gated sodium channels in nerve fibres. As a result, it prevents nerve impulse generation and conduction, producing sustained sensory and motor block.

Anaesthetists use Verbupi for infiltration anaesthesia and peripheral nerve block procedures. However, it is not indicated for spinal or caudal anaesthesia. In addition, each ampoule is preservative-free and intended for single-dose use only, which reduces the risk of contamination and adverse reaction. Because of this profile, Verbupi suits operating theatres, surgical day-care units, and pain management procedures where extended local anaesthesia is required.

Key Features:

• Overall, this BP-compliant formulation guarantees pharmaceutical-grade purity
• Additionally, the preservative-free, single-dose format minimizes contamination risk
• Furthermore, each ampoule delivers precise, validated dosage accuracy at 0.5% w/v
• Notably, rigorous purity and sterility testing backs every stage of manufacturing
• Beyond that, light-protected packaging preserves product stability during storage
• Ultimately, a reliable supply chain suits bulk distribution to hospitals, surgical centres, and pharmacies